Stock UniverseDerived research view · source repositories remain read-only

Tandem Diabetes Care, Inc. (TNDM)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Qualified
Selection Score
35.11
Global Rank
1248
Market Cap
1.73B
Latest Close
19.34
RS Composite
-13.77% · G#2318

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
7.27%
3M
-8.51%
6M
-2.96%
1Y
-4.16%
3Y
-25.59%
5Y
-77.35%
10Y
-70.47%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.30M · 30-day average: 2.80M · Max drawdown over stored range: -97.44%

Research Snapshot

Relative Strength vs SPX

RS Composite-13.77%
20D RS4.07%
60D RS-21.70%
120D RS-14.77%
Global RS Rank2318 · 30.91% percentile
Qualified+ RS Rank879 · 30.13% percentile
Group ScopeQualified+
Primary RS Rank83 · 41.55% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank82 / 246
Primary Percentile67.07
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-071.03B564.39M-83.81M-94.55M-1.39-26.44M35.39M-61.83M68M54.93%-8.16%-9.20%-2.57%-6.02%570.26M601.77M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-1.39-13.9x$15.161.3x$-0.91-21.2x$-0.39-49.6x

Shares Diluted: 68M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue702.799801.217747.718940.2031014.736
Revenue Growth (YoY)40.889%14.004%-6.677%25.743%7.927%
Gross Profit376.215412.986367.69489.574546.014
Operating Income22.653-61.809-140.38-99.127-92.089
Free Cash Flow97.17916.367-58.6144.994-29.669
Free Cash Flow Per Share1.510.255-0.9020.076-0.441
EPS (Diluted) GAAP0.24-1.474667-3.426418-1.467128-3.042431
EPS Growth
EPS Non-GAAP
Gross Margin53.531%51.545%49.175%52.071%53.808%
Operating Margin3.223%-7.714%-18.774%-10.543%-9.075%
Profit Margin2.215%-11.806%-29.772%-10.213%-20.174%
Free Cash Flow Margin13.827%2.043%-7.839%0.531%-2.924%
Shares Outstanding (Diluted)64.34964.14664.96965.45167.285
Shares Change (YoY)5.507%-0.315%1.283%0.742%2.802%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-07247.22M55.33%-17.43M-7.05%-20.39M-8.25%-0.3068.40M570.26M601.77Mprocessed
2025 Q42026-02-19290.38M57.67%8.29M2.86%-589.00K-0.20%-0.0168.02M292.67M310.04Mprocessed
2025 Q32025-11-06249.25M53.88%-22.86M-9.17%-21.16M-8.49%-0.3167.65M319.11M309.59Mprocessed
2025 Q22025-08-06240.68M52.29%-51.81M-21.53%-52.40M-21.77%-0.7867.05M315.36M309.15Mprocessed
2025 Q12025-04-30234.42M50.51%-120.88M-51.56%-130.56M-55.69%-1.9766.40M368.62M308.70Mprocessed
2024 Q42025-02-26282.65M55.71%-582.00K-0.21%755.00K0.27%0.0165.94M438.33M308.27Mprocessed
2024 Q32024-11-06243.97M51.09%-26.09M-10.70%-23.25M-9.53%-0.3565.54M473.31M307.83Mprocessed
2024 Q22024-08-01221.91M50.83%-30.77M-13.87%-30.81M-13.89%-0.4764.99M452.42M307.39Mprocessed
2024 Q12024-05-02191.67M49.39%-41.68M-21.74%-42.72M-22.29%-0.6565.33M467.81M347.50Mprocessed
2023 Q42024-02-21196.80M47.41%-35.06M-17.82%-30.00M-15.25%-0.4665.37M467.91M285.04Mprocessed
2023 Q32023-11-01185.62M48.35%-31.55M-16.99%-32.96M-17.76%-0.5165.12M498.16M284.58Mprocessed
2023 Q22023-08-03195.92M51.93%-38.81M-19.81%-35.77M-18.26%-0.5564.83M507.25M284.13Mprocessed
2023 Q12023-05-03169.38M48.95%-127.82M-75.46%-123.87M-73.13%-1.9264.55M519.59M283.68Mprocessed
2022 Q42023-02-22220.50M52.39%-17.78M-8.06%-15.85M-7.19%-0.2564.38M616.90M283.23Mprocessed
2022 Q32022-11-02204.55M51.05%-47.49M-23.22%-48.97M-23.94%-0.7664.24M608.73M282.79Mprocessed
2022 Q22022-08-03200.26M50.91%-12.24M-6.11%-15.06M-7.52%-0.2464.08M635.33M282.35Mprocessed
2022 Q12022-05-04175.91M51.78%-15.34M-8.72%-14.71M-8.37%-0.2363.88M635.39M281.90Mprocessed
2021 Q42022-02-22210.00M54.16%12.74M6.07%10.81M5.15%0.1764.80M623.81M281.47Mprocessed
2021 Q32021-11-03179.63M53.86%7.72M4.30%5.79M3.23%0.0964.78M594.99M281.03Mprocessed
2021 Q22021-08-04172.14M53.71%5.43M3.16%4.01M2.33%0.0665.66M545.30M280.60Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.